Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Quantifying psilocybin exposure in a natural product-based retreat setting: An observational field method for dose measurementPsychedelics · 2026-12-01Mindfulness-Based Psilocybin-Assisted Therapy (MB-PAT) for cancer-related demoralization in Canada: The case for a hybrid group-based delivery modelPsychedelics · 2026-12-01Prevalence and Reasons for Microdosing Cannabis, Psilocybin, LSD, and MDMA Among U.S. AdultsAmerican Journal of Preventive Medicine · 2026-10-01Single-crystal structure determination of psilocybin after dehydrationActa Crystallographica Section C Structural Chemistry · 2026-09-01Assessing The Readiness of Psychiatrists in Louisiana to Incorporate Psilocybin into Clinical Practice-Lessons Learned from a State Underrepresented in Clinical Psychedelic Research.Psychedelic medicine (New Rochelle, N.Y.) · 2026-09-01Psilocybin-assisted psychotherapy for substance use disorders as a complex intervention: A systematic review of efficacy, mechanisms and psychotherapeutic frameworksJournal of Psychopharmacology · 2026-08-17Defining 'psychedelic'.Journal of psychopharmacology (Oxford, England) · 2026-08-17Subacute and long-term changes in cognitive functioning after administration of classic psychedelics, MDMA and ketamine: A systematic review of clinical and preclinical evidence.Neuroscience and biobehavioral reviews · 2026-08-14Efficacy and Safety of Psychedelic Microdosing on Psychological Outcomes in Healthy Adults: A Systematic Review and Meta-analysis.CNS drugs · 2026-08-13Psilocybin Recovery Intervention for Stopping Methamphetamine UseClinicalTrials.gov · 2026-08-11A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-08-10Feasibility and Tolerability of Psilocybin for Phantom Limb Pain.The journal of pain · 2026-08-07Psilocybin-assisted therapy for treatment-resistant major depressive disorder in a public healthcare setting: a randomized controlled trial.Nature medicine · 2026-08-06Single Dose Psilocybin for a Post-surgical Trauma Inpatient Population for Pain, Mood, and Opioid Use DisorderClinicalTrials.gov · 2026-08-06A suite of engineered mice for interrogating psychedelic drug actions.Nature neuroscience · 2026-08-06Feasibility Phase 2 Study of Psilocybin-Assisted Therapy for Opioid-Refractory Pain in Patients With Advanced CancerClinicalTrials.gov · 2026-08-05Psychedelics and women's mental health: the effects of female sex hormones on psychedelics' efficacy and tolerability.Molecular psychiatry · 2026-08-04Safety and Efficacy of Psilocybin During Anticancer Treatment: A Phase II Trial Secondary Analysis.Journal of pain and symptom management · 2026-08-03Psilocybin for Fear of Cancer RecurrenceSupportive Care in Cancer · 2026-08-01Cardiovascular safety of psilocybin in psychiatric practice: a narrative reviewEuropean Journal of Clinical Pharmacology · 2026-08-01Ethical Complexities and Best Practices in Informed Consent Processes for Psilocybin Services: A Qualitative StudyNeuroethics · 2026-08-01Barriers and Facilitators for Psychedelic Research and Regulation in Brazil: Insights From Diverse Stakeholders.Clinical therapeutics · 2026-08-01The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysisJournal of Affective Disorders · 2026-08-01A25-year analysis of Armillaria (honey mushroom) poisoning in Wisconsin.The American journal of emergency medicine · 2026-08-01Safety, feasibility, and preliminary clinical outcomes of psilocybin-assisted therapy for veterans with severe, treatment-resistant PTSD: an open-label pilot clinical trialCommunications Medicine · 2026-07-30Is BOLD Measurement-Invariant Across Pharmacological State? A Pre-Registered Test of Haemodynamic Response Function Drug-Invariance Using Simultaneous EEG-fMRI (PsiConnect)Open MIND · 2026-07-28Convergent neuroimmune signaling underlying rapid antidepressant response to ketamine and psychedelics.Molecular psychiatry · 2026-07-28Network Pharmacology-Guided Discovery of Fungal Autophagy Modulators for Tauopathies: Structural and Proteomic EvidencebioRxiv · 2026-07-27No evidence for deleterious effects of psilocybin and MDMA on working memory or related neurophysiological activity in a non-clinical population: An uncontrolled exploratory studyJournal of Psychopharmacology · 2026-07-23Longitudinal neural and psychological changes following psilocybin under compassion imagery primingFrontiers in Human Neuroscience · 2026-07-22A randomized, double-blind, placebo-controlled single-ascending-dose study to identify a non-hallucinogenic dose of psilocybin in healthy adultsmedRxiv · 2026-07-19Integrated 5-HT-TrkB and G protein signaling in serotonergic psychedelic responses.Molecular psychiatry · 2026-07-16Shurooms: The First Ethnomycological Study from Within the African Initiatory Tradition - Ewe, Soma, and the Ceremonial Architecture of Psilocybin Healing (N = 300+)Zenodo (CERN European Organization for Nuclear Research) · 2026-07-14Reporting practices in psilocybin-assisted therapy trials for depression: A descriptive review and temporal overviewJournal of Psychedelic Studies · 2026-07-13Psychedelics produce enduring enhancement of reward responsiveness in male rats.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2026-07-10Psilocybin therapy for adult females with anorexia nervosa: pilot studyThe British Journal of Psychiatry · 2026-07-08Synthesis and Biological Evaluation of 4-Bromo-dimethyltryptamine (4-Br-DMT): A Synthetic Building Block for Future Analog Development.ACS omega · 2026-07-07CSF galanin and noradrenaline downregulation by psilocybin therapy in major depressive disorderNeuropsychopharmacology · 2026-07-07Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical DevelopmentBiomolecules · 2026-07-03Trajectories of psychedelic-assisted change: An observational study of a psilocybin retreat program followed by psychotherapeutic interventionsJournal of Psychedelic Studies · 2026-07-03Psilocybin as a Transdiagnostic Treatment for Eating Disorders and Comorbid Psychopathology: Implications for Clinical Nosology and Research DirectionsInternational Journal of Eating Disorders · 2026-07-02Acceptability and safety of two sequential doses of psilocybin in bipolar II depression: protocol for an open-label single-arm feasibility studyBMJ Open · 2026-07-01Modeled Long-Term Effects of Psilocybin on Dynamic Activity and Effective Connectivity of Fronto-Striatal-Thalamic CircuitsHuman Brain Mapping · 2026-07-01Revealing shortcomings in the assessment of psilocybin effects on OCD-related symptoms in preclinical and clinical studies: A systematic reviewJournal of Affective Disorders Reports · 2026-07-01Daily self-assessment within a regimen of microdosing indicates enhanced psychological functioning on microdosing days relative to non-microdosing days.Psychopharmacology · 2026-07-01Blinding Integrity in Psychedelic Randomized Clinical Trials: A Systematic Review.JAMA psychiatry · 2026-07-01Implementing psilocybin-assisted therapy in palliative care settings: A survey of stakeholdersPalliative Medicine · 2026-07-01Psilocybin improves novel object recognition in a rat model of Fragile X Syndrome through the modulation of the BDNF/TrkB signaling pathway.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2026-07-01Recreational drug poisonings reported to six European poison centres from 2021 to 2024.Clinical toxicology (Philadelphia, Pa.) · 2026-07-01Acute dose-dependent effects of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) compared with 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin in a double-blind, placebo-controlled study in healthy participantsNeuropsychopharmacology · 2026-07-01Study Protocol for “Exploring the safety and therapeutic potential of psilocybin in the treatment of anorexia nervosa in adolescents and young adults”PLOS One · 2026-06-30Psilocybin reduces fear memory and restores neuroplasticity in the hippocampus and medial prefrontal cortexJournal of Psychopharmacology · 2026-06-28PSILOCYBIN IN THE TREATMENT OF DEPRESSIVE DISORDERS: CLINICAL EVIDENCE AND ITS POTENTIAL TO ADDRESS THE GLOBAL MENTAL HEALTH CRISIS - A REVIEWInternational Journal of Innovative Technologies in Social Science · 2026-06-24Multi-metric evaluations of acute psychedelic effects on fMRI brain entropy.Nature communications · 2026-06-24Psychedelics and autism spectrum disorder: Mechanistic insights, translational evidence and ethical challenges.Journal of psychiatric research · 2026-06-23Blocking 5-HT2B receptors abolishes psilocybin's efficacy in the rat forced swim test.Journal of psychopharmacology (Oxford, England) · 2026-06-23DESI-MSI-Based Multi-Organ Distribution Mapping of Psilocin in ZebrafishMolecules · 2026-06-18Community engagement as a foundation for implementation research for group psilocybin assisted therapy in New MexicoFrontiers in Public Health · 2026-06-17Short- and Long-Acting Psychedelics: Structure-Activity Relationships, Pharmacology, and Implications for Neuropsychiatric Therapeutics.ACS chemical neuroscience · 2026-06-17The Acute Effects of Psilocybin on Cognition, Memory, and Brain FunctionClinicalTrials.gov · 2026-06-15Psilocybin and Mental Health Outcomes: Scoping Review with ☸️SAIMSARASAIMSARA Journal · 2026-06-15Psychedelics relax predictive processing in the post-acute period by remodeling cortico-cortical feedback circuits.bioRxiv: the preprint server for biology · 2026-06-15Dextromethorphan Beyond the Cough: Exploring Its Psychedelic Potential: A Systematic ReviewCNS Drugs · 2026-06-14EEG microstate dynamics during psilocybin intoxication relate to acute experience and persisting psychological changesbioRxiv · 2026-06-12Alcohol consumption and substance use among French medical students: A nationwide cross-sectional study: Consommation d'alcool et de substances chez les étudiants en médecine de France: une étude transversale nationale.Canadian journal of psychiatry. Revue canadienne de psychiatrie · 2026-06-09Prenatal stress, excitatory-inhibitory imbalance, and ADHD risk: a hypothesis-driven perspective on psilocybin-induced neuroplasticityTranslational Psychiatry · 2026-06-05Developing Methods for Observing Awe Narration in Psilocybin-Assisted TherapyHealthcare · 2026-06-05One dose of Psilocybin modulates Brain Activity among Depressive patients: Preliminary Neuroimaging Results from the PSILODAC StudyEuropean Psychiatry · 2026-06-01Demoralization in Psilocybin-Assisted Therapy for Advanced Cancer: An Exploratory Network AnalysisJournal of Pain and Symptom Management · 2026-06-01Psilocybin: Chemical Foundations and Emerging Therapeutic PotentialMini-Reviews in Medicinal Chemistry · 2026-06-01Lifetime psychedelic use and opioid use disorder severity in a National Survey: the roles of psychedelic type and mental health.Addictive behaviors · 2026-06-01Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulationsPsychiatry and Clinical Neurosciences · 2026-06-01Mapping cognitive-behavioral approach in psychedelic-assisted treatment: a systematic review across phases with classic and non-classic psychedelics.European archives of psychiatry and clinical neuroscience · 2026-06-01Reorganization of Human Brain Waves Across Diverse States of Consciousness.bioRxiv: the preprint server for biology · 2026-06-01Therapeutic advances in fibromyalgia: one year in review 2026.Clinical and experimental rheumatology · 2026-06-01Psilocybin-assisted cognitive behavioral therapy for major depressive disorder: A pilot trialJournal of Affective Disorders · 2026-06-01Effect of psilocybin-assisted psychotherapy on anxiety symptoms: A systematic review and meta-analysisJournal of Psychedelic Studies · 2026-05-29Effects of psilocybin on sleep quality and brain microstructure in chronic cluster headacheJournal of Psychopharmacology · 2026-05-29Psilocybin-induced neurocardiogenic syncope: a case reportPsychopharmacology · 2026-05-28Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression: 6- and 12-Month Naturalistic Follow-Up of a Phase 2b TrialPsychotherapy and Psychosomatics · 2026-05-27Environmental and Internal Gating of Memory: ARCH Multiplicative Threshold Framework for Encoding and RetrievalPreprints.org · 2026-05-26Appetite for change: How psilocybin reshapes food reward learning through striatal dopamine functionbioRxiv · 2026-05-18Short-Term and Late-Term Effects of Psilocybin on Symptoms in Major DepressionJAMA Network Open · 2026-05-15Psilocybin-Assisted Therapy for Adolescent Anorexia Nervosa: Clinical Considerations and Emerging Models of CareCurrent Psychiatry Reports · 2026-05-14From Trials to Clinics: Considerations for Implementing Psychedelic-Assisted Therapy Into Clinical PracticePharmacology Research & Perspectives · 2026-05-101020 Long-term Impact of Psilocybin Administration on Sleep-Continuity via Wearable Sensor Time-series: Preliminary-results in Post-Treatment Lyme DiseaseSLEEPJ · 2026-05-081080 Psilocybin Elicits Non-Linear Night to Night Changes in Sleep Spectral PowerSLEEPJ · 2026-05-08Neural correlates of insight on psilocybin: a within-subjects, healthy volunteer studyJoCN Forum · 2026-05-08Psilocybin in the Treatment of Cocaine Use DisorderJAMA Network Open · 2026-05-07Pilot Results for Psilocybin-Assisted Psychotherapy for Cocaine Use Disorder-A Critical AppraisalJAMA Network Open · 2026-05-07The magic of mushrooms: psilocybin influences behavior in the mangrove rivulus fish, Kryptolebias marmoratusFrontiers in Behavioral Neuroscience · 2026-05-07Human brain changes after first psilocybin useNature Communications · 2026-05-05Effects of Psilocybin Treatment on Cognitive Effort Avoidance in Major Depressive Disorder and Co-Occurring Alcohol Use DisorderJoCN Forum · 2026-05-02Sex-Specific Effects of Psilocin on Paraventricular Nucleus of the Thalamus (PVT) Circuitry and Threat Responding Behavior in Male and Female RatsBiological Psychiatry · 2026-05-01Prohedonic Effects of Psilocybin (COMP360) in a Touchscreen-Based Rodent Probabilistic Reward Task (Abstract ID: 227883)The Journal of Pharmacology and Experimental Therapeutics · 2026-05-01Acute Effects of 4-Bromo-2,5-Dimethoxyphenethylamine (2C-B) Compared With Psilocybin and MDMA in Healthy ParticipantsBiological Psychiatry · 2026-05-01Effects of Psilocybin on Attentional Set-Shifting Following Chronic Unpredictable Stress in Rats (Abstract ID: 231339)The Journal of Pharmacology and Experimental Therapeutics · 2026-05-01SAT-219 Hepatic 5-HT2B receptor antagonism mediates the anti-steatotic and antifibrotic effects of psilocybin in preclinical MASH modelsJournal of Hepatology · 2026-05-01The 3D-ASCr scale: A revalidation of the core dimensions of the Altered States of Consciousness Rating Scale 5D(11)-ASC for psychedelic research.Journal of psychopharmacology (Oxford, England) · 2026-05-01Insights from the psychedelic experience integration session: Verbatims differentiate 3-month abstinence in alcohol use disorder with depressive symptoms.Journal of affective disorders · 2026-05-01Advancing cancer neuroscience through stress modulation: Interdisciplinary potential of psilocybin and ketamineGeneral Hospital Psychiatry · 2026-05-01A randomized clinical trial of repeated doses of psilocybin for the treatment of obsessive-compulsive disorderJournal of Psychopharmacology · 2026-05-01Efficacy and Safety of Psilocybin in Treatment-Resistant Major DepressionJAMA Psychiatry · 2026-05-01Effects of psychedelic use on authoritarian attitudes revisited.Journal of psychopharmacology (Oxford, England) · 2026-05-01Pharmacotherapeutic Management of Depression in Patients With Cancer: A Review of Mechanistic and Clinical Evidence.Cancer reports (Hoboken, N.J.) · 2026-05-01Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial - CORRIGENDUMBJPsych Open · 2026-05-01Integrating the Mystical Experience Questionnaire Into a Broader Psychometric Framework: English Validation of the Psychedelic Experience Scale and Comparison of Psilocybin and LSD Sessions Across Two Controlled SettingsRepository for Publications and Research Data (ETH Zurich) · 2026-04-30Evaluating the evidence for repressed memory recovery in psychedelic contextsPsychopharmacology · 2026-04-28Specific and Multi-Product Clade I and Clade IV Sesquiterpene Synthases Contribute to the Psilocybe cubensis Volatilome.Chembiochem: a European journal of chemical biology · 2026-04-28Fusing Specialized Surveys of Rare Populations to Larger Surveys for Generalized Inference: Cross-Sectional Survey Study.Journal of medical Internet research · 2026-04-27Psilocybin use among Basotho healers and non-healers in southern AfricaOSF Preprints · 2026-04-23A Randomized, Double-Blind Study of Single-Dose Psilocybin for Major Depressive Disorder (MDD)ClinicalTrials.gov · 2026-04-22Prevalence and Correlates of Past-Year Psilocybin Use in the United StatesAmerican Journal of Psychiatry · 2026-04-22The efficacy and safety of psilocybin-assisted therapy for major depressive disorder: a meta-analytic review of clinical outcomesMental Wellness · 2026-04-21Serotonergic Polypharmacology of 2-Halogenated Tryptamines.bioRxiv: the preprint server for biology · 2026-04-21Psychedelics and Autism Therapy: A Review of Current Research and Future Directions.Current issues in molecular biology · 2026-04-18Effects of a single dose of psilocybin on diet-induced weight loss in obese miceTranslational Psychiatry · 2026-04-14A phase 1 study of a second experience with Group Retreat Psilocybin Therapy for partial responders after a first experienceFrontiers in Public Health · 2026-04-14Psilocybin acutely reduces low-frequency BOLD power and frequency-specific connectivitybioRxiv · 2026-04-13Observing the mind under psychedelics: conceptual metaphors used following four once-weekly macrodoses of psilocybinPhilosophical Psychology · 2026-04-10Sex-specific increased reactivity of the PVT and prolonged PVT→CeA circuit engagement following psilocin administrationNature Communications · 2026-04-10Additional file 1 of Evaluation of a facilitator training program in a randomized controlled trial of psilocybin treatment for depressionFigshare · 2026-04-09Evaluation of a facilitator training program in a randomized controlled trial of psilocybin treatment for depressionBMC Medical Education · 2026-04-09Brain-MGF: Multimodal Graph Fusion Network for EEG-FMRI Brain Connectivity Analysis Under Psilocybin2026 IEEE 23rd International Symposium on Biomedical Imaging (ISBI) · 2026-04-08Severe Illness Associated with Eating Mushroom-Containing Chocolate Products - United States, January-October 2024.MMWR. Morbidity and mortality weekly report · 2026-04-08A living systematic review, meta-analysis and open-data resource of randomized controlled trials of psilocybin treatment for symptoms of depressionNature Mental Health · 2026-04-06Complete biosynthesis of psychedelic tryptamines from three kingdoms in plants.Science advances · 2026-04-03Therapeutic Potential of Psilocybin in Psychiatric Disorders: Mechanisms, Efficacy, and Clinical ImplicationsFocus · 2026-04-01Comparing single- and repeat-dose psilocybin with active placebo for migraine prevention in an exploratory randomized controlled clinical trial.Headache · 2026-04-01Consistency of protocol and safety data reporting in clinical trial registrations and corresponding publications of interventions involving MDMA and psilocybinJournal of Clinical Epidemiology · 2026-04-01Methodological moderators of psilocybin-assisted therapy in depression: A systematic review and meta-analysisNeuroscience & Biobehavioral Reviews · 2026-04-01Regulatory ambiguity and governance challenges for psilocybin mushrooms in BrazilInternational Journal of Drug Policy · 2026-04-01Clinical Characteristics of Emergency Visits Related to Recreational Psychedelic Use.Community mental health journal · 2026-04-01An international mega-analysis of psychedelic drug effects on brain circuit function.Nature medicine · 2026-04-01Psychedelic-assisted pharmacotherapy: clinical applications and regulatory considerations.Expert opinion on pharmacotherapy · 2026-04-01Mystical dynamics: renewal, luminous light, and ego disintegration as key features associated with mystical oneness-a psychometric analysis using the PES100 in controlled psychedelic studiesReligion Brain & Behavior · 2026-03-31Reshaping human neurons.eLife · 2026-03-31Psilocybin Assisted Psychotherapy for Treatment Resistant Depression and Co-occurring Substance Use DisorderClinicalTrials.gov · 2026-03-30Strong alliance, weak conclusions: Comment on Goodwin et al. (2026) “The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression”PsyArXiv · 2026-03-30Psychedelic Experiences and Finitude in Serious Illness: A Qualitative SynthesisJournal of Pain and Symptom Management · 2026-03-26Safety and Efficacy of Psilocybin-Assisted Therapy for Alcohol Use Disorder: Open-Label Extension of a Phase II Randomized Controlled TrialPsyArXiv · 2026-03-26Integrated 5-HT -TrkB and G protein signaling in serotonergic psychedelic responses.bioRxiv: the preprint server for biology · 2026-03-23Psilocybin retail stores in Canada: Changes in availability, commercialization, and geographic distributionCanadian Journal of Public Health · 2026-03-19Synthesis and Characterization of Psilocybin Metabolites and Deuterated AnalogsACS Chemical Neuroscience · 2026-03-18Digital Intervention for Psychedelic Preparation (DIPP): protocol for a randomised controlled feasibility trial comparing meditation- and music-based programmes in healthy volunteers.BMJ open · 2026-03-12Oregon's Emerging Psilocybin Services Workforce: A Survey of the First Legal Psilocybin Facilitators and Their Training ProgramsPsyArXiv · 2026-03-11Age moderates the relationship between psychedelics use and mental health in naturalistic settingsResearch Square · 2026-03-10Psilocybin or Nicotine Patch for Smoking CessationJAMA Network Open · 2026-03-10Behavioural investigations of psilocybin in non-human animals 1962-2021: A scoping reviewJournal of Psychedelic Studies · 2026-03-09THE EFFECT OF PSILOCYBIN AND EUGENOL ON LIPOPOLYSACCHARIDE INDUCED INFLAMMATION IN SMALL AND LARGE INTESTINE OF MICEZenodo (CERN European Organization for Nuclear Research) · 2026-03-01Safety and Efficacy of Monoamine Oxidase Inhibitors in Patients Who Use Psychoactive Substances: Potential Drug Interactions and Substance Use Disorder Treatment Data.CNS drugs · 2026-03-01Psilocybin and Ibogaine in Cocaine-Seeking: Extinction Enhancement Without Relapse PreventionAddiction Biology · 2026-03-01Breaking the chains of depression: A systematic review and meta-analysis of psilocybin therapyJournal of Affective Disorders · 2026-03-01Cost-Effectiveness of Psilocybin-Assisted Therapy Versus Standard of Care for Patients With Treatment-Resistant DepressionValue in Health Regional Issues · 2026-03-01The Psychological Support Model in Psilocybin Research: Psychotherapy in Disguise?Psychiatric Research and Clinical Practice · 2026-03-01Psilocybin-assisted therapy for demoralisation in hospice patients: feasibility, safety and preliminary efficacy.BMJ supportive & palliative care · 2026-02-27Psychedelic therapy and cultural humility.Translational psychiatry · 2026-02-27Pilot study of psilocybin in patients with post-treatment lyme diseaseScientific Reports · 2026-02-25Safety and Efficacy of Microdosing Psilocybin over 8 Weeks for Major Depressive Disorder: A Randomized Clinical TrialResearch Square · 2026-02-23Ethical Complexities and Best Practices in Informed Consent for Psychedelic Services: A Qualitative Study on Expert PerspectivesPsyArXiv · 2026-02-19Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial.BJPsych open · 2026-02-16Psilocybin and Animal Testing: Charting an End to the Use of Animals in Drug Development ResearchDigital Commons at University of Maryland Carey Law (University of Maryland Francis King Carey School of Law) · 2026-02-12Design, Synthesis, and Pharmacokinetic Profiling of Fluorinated Reversible N -Alkyl Carbamate Derivatives of Psilocin for Sub-Hallucinogenic Brain ExposureJournal of Medicinal Chemistry · 2026-02-12Time-Dependent Effects of Rapid-Acting Antidepressants in iPSC-Derived Neurons from Treatment-Resistant Depression and Healthy Volunteers.Research square · 2026-02-12India's Unique Legal Framework for Psilocybin Mushroom Research: An Unprecedented Opportunity in Psychiatric Therapeutics.Indian journal of psychological medicine · 2026-02-05Approved and Pipeline Pharmacological Interventions for Eating Disorders (2010-2025): 15 Years of Progress (or Lack Thereof).CNS drugs · 2026-02-01Psilocybin in the real world: Regulatory, ethical, and operational challenges in Australia's clinical landscape.The Australian and New Zealand journal of psychiatry · 2026-02-01Patient perspectives on research gaps in cluster headache.Headache · 2026-02-01Psychedelics in psychiatric treatment: a literature reviewQuality in Sport · 2026-01-26Sense-making around psilocybin in UK women experiencing cancer-related existential distress: An Interpretative Phenomenological AnalysisResearch Explorer (The University of Manchester) · 2026-01-09An open-label pilot study of psilocybin-assisted therapy for binge eating disorder.Journal of eating disorders · 2026-01-03Reported Safety Practices of Publicly Advertised Psychedelic Retreats.JAMA network open · 2026-01-02Psychological Therapy Quantity and Depressive Symptom Reduction in Psychedelic-Assisted Therapy: A Systematic Review and Meta-Analysis.JAMA network open · 2026-01-02COMPARATIVE EFFICACY AND ACCEPTABILITY OF PSILOCYBIN-KETAMINE AND TYPICAL ANTIDEPRESSANTS FOR MAJOR DEPRESSIVE DISORDER MANAGEMENT: A NETWORK META-ANALYSISThe Study of Phenomena Related to Health · 2026-01-01Symptom-level antidepressant response to psilocybin: exploratory outcomes comparing psilocybin treatment to niacinNeuroscience Applied · 2026-01-01Self-reported benefits and harms of microdosing with natural psilocybin: preliminary results from a naturalistic studyNeuroscience Applied · 2026-01-01Additional file 1 of An open-label pilot study of psilocybin-assisted therapy for binge eating disorderFigshare · 2026-01-01Additional file 2 of An open-label pilot study of psilocybin-assisted therapy for binge eating disorderFigshare · 2026-01-01Facing Mortality Together: A Constructivist Grounded Theory Analysis of Group Psilocybin Therapy Among Older Long-Term AIDS Survivor Gay MenPalliative Medicine Reports · 2026-01-01Healthcare Providers' Perspectives on Psychedelic-Assisted Therapies Across Clinical Contexts: "I Can Offer Medical Assistance in Dying, but I Can't Prescribe Psychedelics".Global advances in integrative medicine and health · 2026-01-01Mismatch between psilocybin-induced head-twitch behaviour and psilocin brain levels in miceNeuroscience Applied · 2026-01-01Preliminary results from an ongoing naturalistic survey study investigating dose-finding practices and effects of self-administered small amounts of psilocybinNeuroscience Applied · 2026-01-01Down the Rabbit Hole: A Large-Scale Survey of Psychedelic Users' Patterns of Use and Perceived Effects.Journal of psychoactive drugs · 2026-01-01Building standards of psychedelic care: Qualitative examination of expert perspectives on safety, inclusion, and accountability.The International journal on drug policy · 2026-01-01Investigating the safety and tolerability of single-dose psilocybin for post-traumatic stress disorder: A nonrandomized open-label clinical trial.Journal of psychopharmacology (Oxford, England) · 2026-01-01Psychedelic Drug Checking: Analytical and Strategic Challenges in Harm Reduction for Classic Psychedelics.Current topics in behavioral neurosciences · 2026-01-01Effects of psychedelic microdosing on cognitive functions: A systematic review and meta-analysis.Neuroscience and biobehavioral reviews · 2026-01-01The Effect of Magic Mushroom (Psilocybe azurescens) on Social Interaction, Anxiety- and Depressive-Like Behaviors in Male Rats; the Role of Neuroinflammation, Oxidative Stress, and Neurotrophic Factors.Journal of neuroscience research · 2026-01-01Pharmacological Management of Anxiety in End-of-Life Care: A Systematic Review of Benzodiazepines, Opioids, and Psilocybin.Human psychopharmacology · 2026-01-01Rural-Urban Disparities in Access to Interventional Psychiatry Treatments among VA Patients.Rural mental health · 2026-01-01Psychedelic-assisted therapy: a survey on the clinical methods of Swiss physicians.Therapeutic advances in psychopharmacology · 2026-01-01Self-Transcendent Perceptual Dynamics and the Effects of Dispositional Mindfulness on Altered States of Consciousness: A Prospective Longitudinal Observational Study of a Naturalistic Psychedelic RetreatPsyArXiv · 2025-12-31A Systematic Review of the efficacy, safety, and Tolerability of Psychedelics in the Treatment of post-traumatic Stress DisorderCurrent Treatment Options in Psychiatry · 2025-12-25The genus Psilocybe in ItalyItalian Botanist · 2025-12-22The CAnadian Network for Psychedelic-Assisted Cancer Therapy (CAN-PACT): A Multi-Phase Program Overview.Current oncology (Toronto, Ont.) · 2025-12-22Cognitive outcomes following psilocybin-assisted therapy in treatment-resistant depression: A post-hoc analysis of a randomized, waitlist-controlled trial.Progress in neuro-psychopharmacology & biological psychiatry · 2025-12-20The Psychedelic Psilocin Suppresses Activity of Central Amygdala Corticotropin-Releasing Factor Receptor 1 Neurons and Decreases Ethanol Drinking in Female MiceThe Journal of Neuroscience · 2025-12-10Are Magic Mushrooms the Magic to Healing?DigitalCommons - Kennesaw State University (Kennesaw State University) · 2025-12-07Questioning the recovery of dissociated traumatic memories under psilocybin: comment on "Therapeutic emergence of dissociated traumatic memories during psilocybin treatment for anorexia nervosa".Journal of eating disorders · 2025-12-04Between enhancement and risk: A critical review of psychedelic microdosing.Current opinion in psychology · 2025-12-01